In late summer 2012, Bayer HealthCare plans to open the CoLaborator™ at its one year old U.S. Innovation Center, Mission Bay, CA. The CoLaborator is planned to be a 550 m2 shared lab for three to four start-up life science companies whose technology platforms, drug targets, or drug candidates align with Bayer’s portfolio.
The goal is to support start-ups in establishing their research labs, with academic researchers spinning out new firms and venture capital groups being the likely sources of these companies. In return for low-cost, ready to use lab space and access to its global expertise, Bayer would seek preferred access to partner with the emerging companies.
- Bayer HealthCare, Leverkusen, Germany
